THYROID CARCINOMA
Clinical trials for THYROID CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new THYROID CARCINOMA trials appear
Sign up with your email to follow new studies for THYROID CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Major cancer trial tests new hope for patients Who've run out of options
Disease control OngoingThis study tested pembrolizumab, an immunotherapy drug, in people with advanced solid tumors who had already tried standard treatments that stopped working. Researchers enrolled 1,609 participants with various cancers including anal, cervical, lung, and thyroid cancers to see how…
Matched conditions: THYROID CARCINOMA
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
Drug safety watch for advanced thyroid cancer treatment
Disease control OngoingThis study is monitoring the safety and long-term effectiveness of the drug sorafenib (NEXAVAR®) in patients with advanced thyroid cancer that cannot be removed by surgery. It will follow 453 patients in Japan for up to two years to track side effects and survival rates. The goal…
Matched conditions: THYROID CARCINOMA
Sponsor: Bayer • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC